Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Immunization schedule in phase 1 trial of avian influenza vaccine completed by Sinovac
May 10th, 2006
Sinovac Biotech Ltd. (SVA) announced that all 120 volunteers in the phase 1 clinical trial of its avian influenza vaccine (H5N1) have completed the two shot regimen of either the vaccine or a placebo. All 120 volunteers (aged 18-60 years) in the clinical trial were thoroughly evaluated and medically documented prior to entering the vaccination program. The clinical trial was conducted on a 0- and 28-day dose immunization schedule. Sinovac expects to take blood samples from volunteers to analyze the antibody growth and effectiveness of the vaccine. Sinovac Biotech Ltd. is a Chinese biopharmaceutical company, focused on research,...
Source: Vaccine Weekly (2006-05-10)
|
